This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Arrowhead Pharmaceuticals, Inc.. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Pankaj Kumar - Innovator in Targeting Ligands
Introduction
Pankaj Kumar is a distinguished inventor based in Madison, WI (US). He has made significant contributions to the field of therapeutic compounds, particularly in the development of novel targeting ligands.
Latest Patents
Pankaj Kumar holds two patents, with his latest focusing on targeting ligands. These ligands are designed to be linked to therapeutic compounds, enabling precise direction to in vivo targets. The ligands can effectively target expression-inhibiting oligomeric compounds, such as RNAi agents, specifically to liver cells, thereby modulating gene expression. This innovation has potential applications in therapeutic, diagnostic, target validation, and genomic discovery fields. The compositions that include these targeting ligands, when linked to expression-inhibiting oligomeric compounds, can mediate the expression of target nucleic acid sequences in liver cells, which may be beneficial in treating diseases that require inhibition of gene expression.
Career Highlights
Pankaj Kumar is currently employed at Arrowhead Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work is pivotal in creating innovative solutions for gene expression modulation.
Collaborations
Throughout his career, Pankaj has collaborated with notable colleagues, including Zhen Li and Tao Pei. These collaborations have further enriched his research and contributed to the success of his
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile